US Drug Eluting Sinus Stent (DESS) Market: Size, Trends & Forecasts (2016-2021)
Scope of the Report
The report entitled “US Drug Eluting Sinus Stent (DESS) Market: Size, Trends & Forecasts (2016-2021)”, provides analysis of the US DESS market, with detailed analysis of market size and growth, penetration, market share and economic impact of the industry. The analysis includes the market by value (TAM), by volume and by utilization. The report also provides the analysis of the US sinus surgery market, including analysis of FESS market and BSD market.
Furthermore, the report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall US DESS market has also been forecasted for the years 2016-2021, taking into consideration the growth pattern of sinus surgery market, the growth drivers and the current and future trends.
Intersect is the only company manufacturing drug eluting sinus stents, but the competitive landscape of the market includes other indirect competitors, such as Medtronic, Entellus Medical and Acclarent (J&J), whose company profiling has been done in the report. In this segment of the report, business overview, financial overview and business strategies of the companies are provided.
Company Coverage
Sinuses are the hollow cavities located in the bones of the face and around the nose. There are four sinus cavities: frontal, maxillary, ethmoid, and sphenoid, each with different features. Under normal conditions, the secretion (mucous) flow through the nasal passages, but with the onset of sinusitis, the secretion gets blocked in the sinuses due to inflammation. Sinusitis disturbs the normal lifestyle of a person and sometimes become frustrating, as it affects the person’s breathing, sleeping and eating.
Sinusitis can be divided into Acute Sinusitis, Recurrent Acute Rhinosinusitis (RARS) and chronic Rhinosinusitis (CRS), on the basis of the duration of the episode of sinusitis and its severity. The treatment options for the sinusitis can be over-the-counter treatment, medical management and surgery. The OTC treatment includes decongestants, antihistamines, pain relievers and nasal irrigation. Medical management includes antibiotics and oral and nasal steroids. The sinus surgeries are mainly of two types: Functional Endoscopic Sinus Surgery (FESS) and Balloon Sinus Dilation (BSD).
Intersect, is the only company that has developed drug releasing bio-absorbable implants (drug eluting sinus stents- DESS) that enable targeted and sustained release of therapeutic agents, increasing the effectiveness of the sinus surgery.
The US DESS market is expected to increase at a significant growth rate during the forecasted period (2016-2021). The US DESS market is supported by various growth drivers, such as limitations of FESS treatment, benefits of DESS, increasing per capita healthcare expenditure, cost effectiveness of DESS, etc. Yet, the market faces certain challenges, such as, reimbursement issues, dependability on individual physician’s experience, limited trials after BSD, etc.
The report entitled “US Drug Eluting Sinus Stent (DESS) Market: Size, Trends & Forecasts (2016-2021)”, provides analysis of the US DESS market, with detailed analysis of market size and growth, penetration, market share and economic impact of the industry. The analysis includes the market by value (TAM), by volume and by utilization. The report also provides the analysis of the US sinus surgery market, including analysis of FESS market and BSD market.
Furthermore, the report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall US DESS market has also been forecasted for the years 2016-2021, taking into consideration the growth pattern of sinus surgery market, the growth drivers and the current and future trends.
Intersect is the only company manufacturing drug eluting sinus stents, but the competitive landscape of the market includes other indirect competitors, such as Medtronic, Entellus Medical and Acclarent (J&J), whose company profiling has been done in the report. In this segment of the report, business overview, financial overview and business strategies of the companies are provided.
Company Coverage
- Intersect ENT
- Medtronic (Xomed)
- Entellus Medical
- Acclarent (J&J)
Sinuses are the hollow cavities located in the bones of the face and around the nose. There are four sinus cavities: frontal, maxillary, ethmoid, and sphenoid, each with different features. Under normal conditions, the secretion (mucous) flow through the nasal passages, but with the onset of sinusitis, the secretion gets blocked in the sinuses due to inflammation. Sinusitis disturbs the normal lifestyle of a person and sometimes become frustrating, as it affects the person’s breathing, sleeping and eating.
Sinusitis can be divided into Acute Sinusitis, Recurrent Acute Rhinosinusitis (RARS) and chronic Rhinosinusitis (CRS), on the basis of the duration of the episode of sinusitis and its severity. The treatment options for the sinusitis can be over-the-counter treatment, medical management and surgery. The OTC treatment includes decongestants, antihistamines, pain relievers and nasal irrigation. Medical management includes antibiotics and oral and nasal steroids. The sinus surgeries are mainly of two types: Functional Endoscopic Sinus Surgery (FESS) and Balloon Sinus Dilation (BSD).
Intersect, is the only company that has developed drug releasing bio-absorbable implants (drug eluting sinus stents- DESS) that enable targeted and sustained release of therapeutic agents, increasing the effectiveness of the sinus surgery.
The US DESS market is expected to increase at a significant growth rate during the forecasted period (2016-2021). The US DESS market is supported by various growth drivers, such as limitations of FESS treatment, benefits of DESS, increasing per capita healthcare expenditure, cost effectiveness of DESS, etc. Yet, the market faces certain challenges, such as, reimbursement issues, dependability on individual physician’s experience, limited trials after BSD, etc.
1. EXECUTIVE SUMMARY
2. INTRODUCTION
2.1 Sinus Overview
2.1.1 Types of Sinus
2.2 Sinusitis Overview
2.2.1 Types of Sinusitis
2.2.2 Treatment Options
2.3 Drug Eluting Sinus Stents (DESS) Overview
3. US MARKET ANALYSIS
3.1 US Sinus Surgery Market: An Analysis
3.1.1 US Sinus Surgery Market by Addressable Population
3.1.2 US Sinus Surgery Market by Sinusitis Patients
3.1.3 US Sinus Surgery Market by Chronis Sinusitis Patients
3.1.4 US Sinus Surgery Market by Annual Office Visits
3.1.5 US Sinus Surgery Market by Number of ENT Eligible Patients
3.1.6 US Sinus Surgery Market by Patient Segmentation
3.1.7 US Sinus Surgery Market by Number of Procedures
3.2 US Functional Endoscopic Sinus Surgery (FESS) Market Analysis
3.2.2 US FESS Market by Number of Procedures
3.3 US Balloon Sinus Dilation (BSD) Market Analysis
3.3.1 US BSD Market by Number of Procedures
3.3.2 US BSD Market by Penetration and ASP
3.3.3 US BSD Market by Value
3.3.4 US BSD Market by Segments
3.3.5 US Operating Room (OR) BSD Market Analysis
3.3.6 US Office BSD Market Analysis
3.4 US Drug Eluting Sinus Stent (DESS) Market: An Analysis
3.4.1 US DESS Market by TAM
3.4.2 US DESS Market by Utilization and ASP
3.4.3 US PROPEL Market Analysis
4. MARKET DYNAMICS
4.1 Growth Drivers
4.1.1 Rising Per Capita Healthcare Expenditure
4.1.2 Limitations of FESS
4.1.3 Benefits of DESS (PROPEL)
4.1.4 Cost Effectiveness
4.2 Challenges
4.2.1 Use of Oral Steroids and Packaging Material
4.2.2 Reimbursement Issues with Drug Eluting Sinus Stent (DESS)
4.2.3 Dependability on Individual Physician’s Experience
4.2.4 Limited Trials for BSD
4.3 Market Trends
4.3.1 Treatment in Physician’s Office
4.3.2 Move from FESS to BSD
4.3.3 Use of BSD in Frontal Sinuses
4.3.4 3D Technology
4.3.5 Outside US (OUS) DESS Market Opportunity
5. COMPETITIVE LANDSCAPE
5.1 US Sinus Surgery Market Competitive Landscape
5.1.1 US Sinus Surgery Market Players Financial Comparison
5.2 US BSD Market Competitive Landscape
5.2.1 US BSD Market Share by Players
5.2.2 US BSD Market Segmentation by Players
6. COMPANY PROFILING
6.1 Intersect ENT
6.1.1 Business Overview
6.1.2 Financial Overview
6.1.3 Business Strategy
6.2 Medtronic (Xomed)
6.2.1 Business Overview
6.2.2 Financial Overview
6.2.3 Business Strategy
6.3 Entellus Medical
6.3.1 Business Overview
6.3.2 Financial Overview
6.3.3 Business Strategy
6.4 Johnson & Johnson (Acclarent)
6.4.1 Business Overview
6.4.2 Financial Overview
6.4.3 Business Strategy
2. INTRODUCTION
2.1 Sinus Overview
2.1.1 Types of Sinus
2.2 Sinusitis Overview
2.2.1 Types of Sinusitis
2.2.2 Treatment Options
2.3 Drug Eluting Sinus Stents (DESS) Overview
3. US MARKET ANALYSIS
3.1 US Sinus Surgery Market: An Analysis
3.1.1 US Sinus Surgery Market by Addressable Population
3.1.2 US Sinus Surgery Market by Sinusitis Patients
3.1.3 US Sinus Surgery Market by Chronis Sinusitis Patients
3.1.4 US Sinus Surgery Market by Annual Office Visits
3.1.5 US Sinus Surgery Market by Number of ENT Eligible Patients
3.1.6 US Sinus Surgery Market by Patient Segmentation
3.1.7 US Sinus Surgery Market by Number of Procedures
3.2 US Functional Endoscopic Sinus Surgery (FESS) Market Analysis
3.2.2 US FESS Market by Number of Procedures
3.3 US Balloon Sinus Dilation (BSD) Market Analysis
3.3.1 US BSD Market by Number of Procedures
3.3.2 US BSD Market by Penetration and ASP
3.3.3 US BSD Market by Value
3.3.4 US BSD Market by Segments
3.3.5 US Operating Room (OR) BSD Market Analysis
3.3.6 US Office BSD Market Analysis
3.4 US Drug Eluting Sinus Stent (DESS) Market: An Analysis
3.4.1 US DESS Market by TAM
3.4.2 US DESS Market by Utilization and ASP
3.4.3 US PROPEL Market Analysis
4. MARKET DYNAMICS
4.1 Growth Drivers
4.1.1 Rising Per Capita Healthcare Expenditure
4.1.2 Limitations of FESS
4.1.3 Benefits of DESS (PROPEL)
4.1.4 Cost Effectiveness
4.2 Challenges
4.2.1 Use of Oral Steroids and Packaging Material
4.2.2 Reimbursement Issues with Drug Eluting Sinus Stent (DESS)
4.2.3 Dependability on Individual Physician’s Experience
4.2.4 Limited Trials for BSD
4.3 Market Trends
4.3.1 Treatment in Physician’s Office
4.3.2 Move from FESS to BSD
4.3.3 Use of BSD in Frontal Sinuses
4.3.4 3D Technology
4.3.5 Outside US (OUS) DESS Market Opportunity
5. COMPETITIVE LANDSCAPE
5.1 US Sinus Surgery Market Competitive Landscape
5.1.1 US Sinus Surgery Market Players Financial Comparison
5.2 US BSD Market Competitive Landscape
5.2.1 US BSD Market Share by Players
5.2.2 US BSD Market Segmentation by Players
6. COMPANY PROFILING
6.1 Intersect ENT
6.1.1 Business Overview
6.1.2 Financial Overview
6.1.3 Business Strategy
6.2 Medtronic (Xomed)
6.2.1 Business Overview
6.2.2 Financial Overview
6.2.3 Business Strategy
6.3 Entellus Medical
6.3.1 Business Overview
6.3.2 Financial Overview
6.3.3 Business Strategy
6.4 Johnson & Johnson (Acclarent)
6.4.1 Business Overview
6.4.2 Financial Overview
6.4.3 Business Strategy
LIST OF FIGURES
Figure 1: Types of Sinuses
Figure 2: Types of Sinusitis
Figure 3: Treatment Options for Sinusitis
Figure 4: US Sinus Surgery Market by Addressable Population; 2015-2021 (Million)
Figure 5: US Sinus Surgery Market by Sinusitis Patients and Penetration; 2015-2021 (Patients ‘000)
Figure 6: US Sinus Surgery Market by Number of Chronic Sinusitis Patients and Penetration; 2015-2021
Figure 7: US Sinus Surgery Market by Annual Office Visits for CRS; 2015-2021 (‘000)
Figure 8 US Sinus Surgery Market by Annual Office Visits for Acute Sinus; 2015-2021 (‘000)
Figure 9: US Sinus Surgery Market by Number of ENT Eligible Patients; 2015-2021 (Patients ‘000)
Figure 10: US Sinus Surgery Market by Patient Segmentation; 2015-2021 (Patients ‘000)
Figure 11 US Sinus Surgery Market by Number of Procedures; 2015-2021 (Procedures ‘000)
Figure 12: US FESS Market by Number of Procedures; 2015-2021 (Procedures ‘000)
Figure 13: US BSD Market by Number of Procedures; 2015-2020 (Procedures ‘000)
Figure 14: US BSD Market by Penetration and ASP; 2015-2021
Figure 15: US BSD Market by Value; 2015-2021 (US$ Million)
Figure 16: US BSD Market by Segments; 2015 & 2021
Figure 17: US OR BSD Market by Number of Procedures and Penetration; 2015-2021
Figure 18: US OR BSD Market by Value; 2015-2021 (US$ million)
Figure 19: US Office BSD Market by Number of Procedures and Penetration; 2015-2021
Figure 20: US Office BSD Market by Value; 2015-2021 (US$ Million)
Figure 21: US DESS Market by Total Addressable Market; 2015-2021 (US$ Million)
Figure 22: US DESS Market by Utilization and ASP; 2015-2021
Figure 23: US PROPEL Market by Number of Procedure, Units Sold and Value; 2014-2018
Figure 24: US Per-Capita Healthcare Expenditure; 2007-2014 (US$)
Figure 25: Cost Comparison
Figure 26: US BSD Market Share by Players
Figure 27: US OR BSD Market Share by Players; 2015 & 2021
Figure 28: US Office BSD Market Share by Players; 2015 & 2021
Figure 29: Intersect Revenue; 2012-2015 (US$ Million)
Figure 30: Intersect Research and Development Expenditure; 2012-2015 (US$ Million)
Figure 31: Medtronic Net Sales; 2011-2015 (US$ Billion)
Figure 32: Medtronic Net Sales by Segments; 2015
Figure 33: Entellus Revenue; 2012-2015 (US$ Million)
Figure 34: Entellus Revenue by Region; 2015
Figure 35: Johnson & Johnson Total Sales; 2011-2015 (US$ Billion)
Figure 36: Johnson & Johnson Sales by Segments; 2015
Figure 37: Johnson & Johnson Sales by Region; 2015
Table 1: US Sinus Surgery Market Players Financial Comparison
Figure 1: Types of Sinuses
Figure 2: Types of Sinusitis
Figure 3: Treatment Options for Sinusitis
Figure 4: US Sinus Surgery Market by Addressable Population; 2015-2021 (Million)
Figure 5: US Sinus Surgery Market by Sinusitis Patients and Penetration; 2015-2021 (Patients ‘000)
Figure 6: US Sinus Surgery Market by Number of Chronic Sinusitis Patients and Penetration; 2015-2021
Figure 7: US Sinus Surgery Market by Annual Office Visits for CRS; 2015-2021 (‘000)
Figure 8 US Sinus Surgery Market by Annual Office Visits for Acute Sinus; 2015-2021 (‘000)
Figure 9: US Sinus Surgery Market by Number of ENT Eligible Patients; 2015-2021 (Patients ‘000)
Figure 10: US Sinus Surgery Market by Patient Segmentation; 2015-2021 (Patients ‘000)
Figure 11 US Sinus Surgery Market by Number of Procedures; 2015-2021 (Procedures ‘000)
Figure 12: US FESS Market by Number of Procedures; 2015-2021 (Procedures ‘000)
Figure 13: US BSD Market by Number of Procedures; 2015-2020 (Procedures ‘000)
Figure 14: US BSD Market by Penetration and ASP; 2015-2021
Figure 15: US BSD Market by Value; 2015-2021 (US$ Million)
Figure 16: US BSD Market by Segments; 2015 & 2021
Figure 17: US OR BSD Market by Number of Procedures and Penetration; 2015-2021
Figure 18: US OR BSD Market by Value; 2015-2021 (US$ million)
Figure 19: US Office BSD Market by Number of Procedures and Penetration; 2015-2021
Figure 20: US Office BSD Market by Value; 2015-2021 (US$ Million)
Figure 21: US DESS Market by Total Addressable Market; 2015-2021 (US$ Million)
Figure 22: US DESS Market by Utilization and ASP; 2015-2021
Figure 23: US PROPEL Market by Number of Procedure, Units Sold and Value; 2014-2018
Figure 24: US Per-Capita Healthcare Expenditure; 2007-2014 (US$)
Figure 25: Cost Comparison
Figure 26: US BSD Market Share by Players
Figure 27: US OR BSD Market Share by Players; 2015 & 2021
Figure 28: US Office BSD Market Share by Players; 2015 & 2021
Figure 29: Intersect Revenue; 2012-2015 (US$ Million)
Figure 30: Intersect Research and Development Expenditure; 2012-2015 (US$ Million)
Figure 31: Medtronic Net Sales; 2011-2015 (US$ Billion)
Figure 32: Medtronic Net Sales by Segments; 2015
Figure 33: Entellus Revenue; 2012-2015 (US$ Million)
Figure 34: Entellus Revenue by Region; 2015
Figure 35: Johnson & Johnson Total Sales; 2011-2015 (US$ Billion)
Figure 36: Johnson & Johnson Sales by Segments; 2015
Figure 37: Johnson & Johnson Sales by Region; 2015
Table 1: US Sinus Surgery Market Players Financial Comparison
